Literature DB >> 12444120

Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction.

Zohreh Tatari-Calderone1, Roshanak Tolouei Semnani, Thomas B Nutman, Jeffrey Schlom, Helen Sabzevari.   

Abstract

The interaction between CD28 on T cells and CD80 on APCs intensifies the linkage between TCR and MHC at the site of contact between T cells and APCs. In this study, we demonstrate that during human T cell/human APC interaction, the autologous or allogeneic human CD4(+) T cells become positive for the detection of CD80 at an early stage of activation (24 h). This detection of CD80 is attributable to the acquisition of CD80 from APCs, as opposed to the up-regulation of endogenous CD80, as demonstrated by CD4(+) T cells treated with cyclohexamide. Furthermore, no CD80 mRNA could be detected at 24 h in T cells that had acquired CD80 from APCs. CD80 acquisition by T cells from APCs was enhanced upon TCR engagement. The amount of CD80 acquisition by CD4(+) T cells was shown to be related to the expression of CD80 on APCs. Using soluble fusion proteins (soluble CTLA-4, CD28, and CD80) to block either CD28 on the surface of T cells or CD80 on the surface of APCs, it was demonstrated that CD80 acquisition by T cells is mediated through its receptors, possibly CD28 interaction. Moreover, we demonstrate that T cells that have acquired CD80 have the ability to stimulate other T cells. These data thus suggest that CD80 acquisition by human T cells might play a role in the immunoregulation of T cell responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444120     DOI: 10.4049/jimmunol.169.11.6162

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.

Authors:  Anita H Undale; Peter J van den Elsen; Esteban Celis
Journal:  Int Immunol       Date:  2004-09-06       Impact factor: 4.823

2.  Different functional outcomes of intercellular membrane transfers to monocytes and T cells.

Authors:  Kiave-Yune HoWangYin; Estibaliz Alegre; Marina Daouya; Benoit Favier; Edgardo D Carosella; Joel LeMaoult
Journal:  Cell Mol Life Sci       Date:  2010-04       Impact factor: 9.261

3.  Trogocytosis of CD80 and CD86 by induced regulatory T cells.

Authors:  Peng Gu; Julia Fang Gao; Cheryl A D'Souza; Aleksandra Kowalczyk; Kuang-Yen Chou; Li Zhang
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

4.  Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasis.

Authors:  Sven Mostböck; Marta Catalfamo; Yutaka Tagaya; Jeffrey Schlom; Helen Sabzevari
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

5.  CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes.

Authors:  Hui Huang; Siguo Hao; Fang Li; Zhenmin Ye; Junbao Yang; Jim Xiang
Journal:  Immunology       Date:  2007-02       Impact factor: 7.397

6.  The DNA methylation profile of activated human natural killer cells.

Authors:  John K Wiencke; Rondi Butler; George Hsuang; Melissa Eliot; Stephanie Kim; Manuel A Sepulveda; Derick Siegel; E Andres Houseman; Karl T Kelsey
Journal:  Epigenetics       Date:  2016-03-11       Impact factor: 4.528

Review 7.  Therapeutic cancer vaccines: current status and moving forward.

Authors:  Jeffrey Schlom
Journal:  J Natl Cancer Inst       Date:  2012-03-06       Impact factor: 13.506

8.  Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cells.

Authors:  Galit Eisenberg; Ronny Uzana; Aviad Pato; Shoshana Frankenburg; Sharon Merims; Eitan Yefenof; Soldano Ferrone; Tamar Peretz; Arthur Machlenkin; Michal Lotem
Journal:  J Immunol       Date:  2013-04-26       Impact factor: 5.422

9.  Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells.

Authors:  Irina Puliaeva; Kateryna Soloviova; Maksym Puliaiev; Thomas Lang; Roman Puliaev; Charles S Via
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

10.  Editing antigen presentation: antigen transfer between human B lymphocytes and macrophages mediated by class A scavenger receptors.

Authors:  Bohdan P Harvey; Timothy E Quan; Benjamin J Rudenga; Robert M Roman; Joe Craft; Mark J Mamula
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.